Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain

Z Liu1, C Sun, E T Olejniczak

  • 1Pharmaceutical Discovery Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA.

Nature
|January 5, 2001
PubMed

Insights

Smac (DIABLO) binding to inhibitor-of-apoptosis proteins (IAPs) is crucial for activating caspases. This study reveals the structure of a Smac peptide bound to the BIR3 domain of XIAP, aiding cancer therapy development.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Biology

Background:

  • Inhibitor-of-apoptosis proteins (IAPs) are key regulators of programmed cell death, inhibiting caspases.
  • Smac (DIABLO) antagonizes IAPs, promoting caspase activation and apoptosis.
  • The N-terminal residues of Smac are essential for its function, but their structural role in IAP binding is unclear.

Purpose of the Study:

  • To elucidate the structural basis of molecular recognition between Smac and IAPs.
  • To determine the solution structure of the BIR3 domain of XIAP complexed with a Smac-derived peptide.

Main Methods:

  • Nuclear Magnetic Resonance (NMR) spectroscopy to determine the solution structure.
  • Site-directed mutagenesis to analyze Smac peptide and XIAP BIR3 domain interactions.

Main Results:

  • The nine-residue Smac peptide adopts an extended conformation, binding across the third beta-strand of the XIAP BIR3 domain.
  • Only the N-terminal four residues of the Smac peptide directly interact with the BIR3 domain.
  • The complex is stabilized by hydrogen bonds, electrostatic interactions, and hydrophobic interactions.

Conclusions:

  • The determined structure provides critical insights into Smac-IAP molecular recognition.
  • This structural information can guide the design of small molecules targeting IAPs for cancer therapy.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.7K